A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)
Clinical trial NCT02383589 · COMPLETED
Trial details
- NCT number
- NCT02383589
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-26
- Primary completion
- 2018-11-28
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.